Growth Metrics

Enanta Pharmaceuticals (ENTA) Share-based Compensation (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.63%
Dec 31, 2025 -5.55%
Sep 30, 2025 -3.42%
Jun 30, 2025 -10.90%
Mar 31, 2025 -17.26%
Dec 31, 2024 -26.59%
Sep 30, 2024 42.48%
Jun 30, 2024 -2.59%
Mar 31, 2024 -31.34%
Dec 31, 2023 20.59%
Sep 30, 2023 -4.03%
Jun 30, 2023 -4.96%
Mar 31, 2023 3.14%
Dec 31, 2022 4.48%
Sep 30, 2022 -10.13%
Jun 30, 2022 17.49%
Mar 31, 2022 6.75%
Dec 31, 2021 13.24%
Sep 30, 2021 -2.23%
Jun 30, 2021 3.69%
Mar 31, 2021 8.13%
Dec 31, 2020 2.91%
Sep 30, 2020 -0.21%
Jun 30, 2020 -4.46%
Mar 31, 2020 -2.37%
Dec 31, 2019 12.99%
Sep 30, 2019 8.36%
Jun 30, 2019 -11.54%
Mar 31, 2019 -19.44%
Dec 31, 2018 42.17%
Sep 30, 2018 2.11%
Jun 30, 2018 12.12%
Mar 31, 2018 -12.86%
Dec 31, 2017 28.35%
Sep 30, 2017 3.48%
Jun 30, 2017 -11.17%
Mar 31, 2017 6.89%
Dec 31, 2016 30.16%
Sep 30, 2016 1.62%
Jun 30, 2016 3.69%
Mar 31, 2016 19.58%
Dec 31, 2015 10.85%
Sep 30, 2015 13.45%
Jun 30, 2015 10.77%
Mar 31, 2015 39.11%
Dec 31, 2014 29.31%
Sep 30, 2014 2.45%
Jun 30, 2014 3.19%
Mar 31, 2014 109.47%
Dec 31, 2013 25.52%
Sep 30, 2013 19.67%
Jun 30, 2013 -7.00%
Mar 31, 2013 -8.54%
Dec 31, 2012 15.64%
Sep 30, 2012 155.79%
Jun 30, 2012 206.45%